Zante Greg

EDGAR CIK 0001264949

Viking Therapeutics, Inc. - VKTX

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
2
($1.19) M
-31,136 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
07/30/2024
07/31/2024
Sell
-16,136 @ $57.15
 ($922,212) 187,052 (-7.94%) Direct
01/04/2024
01/04/2024
Sell
-15,000 @ $17.90
 ($268,500) 180,730 (-7.66%) Direct